Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities

Arch Pediatr Adolesc Med. 1994 Nov;148(11):1220-4. doi: 10.1001/archpedi.1994.02170110106025.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bacterial / blood
  • Antigens, Bacterial / adverse effects
  • Antigens, Bacterial / immunology
  • Bordetella pertussis / immunology*
  • Female
  • Fimbriae, Bacterial / immunology
  • Hemagglutinins / adverse effects
  • Hemagglutinins / immunology
  • Humans
  • Infant
  • Male
  • Pertussis Vaccine / adverse effects
  • Pertussis Vaccine / immunology*
  • Toxoids / adverse effects
  • Toxoids / immunology
  • Vaccines, Conjugate / adverse effects
  • Vaccines, Conjugate / immunology

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Hemagglutinins
  • Pertussis Vaccine
  • Toxoids
  • Vaccines, Conjugate
  • pertussis toxoid